Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Mitsuhiro Suenaga"'
Publikováno v:
Doboku Gakkai Ronbunshuu E. 65:419-430
高品質吹付けコンクリート(HQSC)は平成9年から整備新幹線トンネル掘削工事に適用され,その使用箇所はH20年7月現在ほぼ130現場に,適用地域は九州から北海道までと全国にわたってい
Autor:
Kenichi Nakashiki, Yoshimune Sakaki, Mitsuhiro Suenaga, Chuwa Tei, Akihiko Yamaguchi, Susumu Itakura, Megumi Umehara, Masaaki Miyata
Publikováno v:
Journal of Cardiology. 51:106-113
Repeated Waon therapy, which uses a far infrared-ray dry sauna system, improved the vascular endothelial function and the cardiac function in patients with chronic heart failure. In patients with chronic obstructive pulmonary disease (COPD), pulmonar
Autor:
Kosei Arimura, Yuji Hamakawa, Kentaro Gejima, Mitsuhiro Suenaga, Hiroki Yoshida, Reiri Onodera, Chuwa Tei, Toshimasa Kukita, Kakushi Matsushita, Naomichi Arima, Nakaaki Kawamata, Hirosaka Inoue, Tetsuo Sato, Akihiko Yamaguchi
Publikováno v:
Acta Haematologica. 116:62-66
A 24-year-old Japanese man was admitted due to bloody phlegm in May 2002. A diagnosis of mediastinal germ cell tumor, mixed type involving seminoma, immature teratoma and embryonal carcinoma, was made by transthoracic needle biopsy. Three months late
Autor:
Mikio Oka, Kazuhiro Tsukamoto, Takashi Nakamura, Minoru Fukuda, Chuwa Tei, Mitsuhiro Suenaga, Ken Shiozawa, Shigeru Kawabata, Hiroshi Soda, Yuji Noguchi, Katsumi Nakatomi, Kenji Terashi, Shigeru Kohno
Publikováno v:
Antimicrobial Agents and Chemotherapy. 44:1697-1700
To investigate interactions between the multidrug resistance protein (MRP) and antimicrobial agents, we examined the effects of 12 agents on vincristine sensitivity and efflux of the calcein acetoxy-methyl ester (calcein-AM) of a MRP substrate in MRP
Autor:
Shigeru Kohno, Yasuaki Yamada, Mikio Oka, Shimeru Kamihira, Hiroshi Soda, Shigeru Kawabata, Midori Soda, Katsumi Nakatomi, Mitsuhiro Suenaga, Takashi Kasai
Publikováno v:
Japanese Journal of Cancer Research : Gann
Smoking prevalence remains high (around 60%) among Japanese males, but smoking initiation among males born in the 1930s decreased by approximately 10% due to economic difficulties following World War II. The present study was designed to examine whet
Autor:
Mitsuhiro, Suenaga, Masatatsu, Yamamoto, Sho, Tabata, Susumu, Itakura, Masaaki, Miyata, Shuichi, Hamasaki, Tatsuhiko, Furukawa
Publikováno v:
Anticancer research. 33(4)
Gefitinib and erlotinib are inhibitors of epidermal growth factor receptor tyrosine kinase. The effects of these tyrosine kinase inhibitors on RAS-mutated cancer cells are unclear.Influence of gefitinib and erlotinib treatment was examined in H23 ade
Publikováno v:
INCoS
Open gate is a user authentication gateway system for network in the environment opened to public. This system has been operating for controlling the campus-wide open network in Saga University since 2001. In this research, we propose to implement hO
Publikováno v:
INCoS
NAPT is one of the most important technologies for Network. Depletion of IPv4 address made conserving IPv4 address with use of NAPT more important issue. Open gate is a user authentication gateway system for network in the environment opened to publi
Autor:
Mitsuhiro, Suenaga, Akihiko, Yamaguchi, Hiroshi, Soda, Koji, Orihara, Yuichi, Tokito, Yoshimune, Sakaki, Megumi, Umehara, Kenji, Terashi, Nakaaki, Kawamata, Mikio, Oka, Shigeru, Kohno, Chuwa, Tei
Publikováno v:
Anticancer research. 26(5A)
Gefitinib (Iressa, ZD1839) is a selective epidermal growth factor receptor tyrosine kinase inhibitor. E2F-1 is a critical determinant in cell cycle. Growth signals up-regulate telomerase activity. The effects of gefitinib on E2F-1 and telomerase in A
Autor:
Junji Tsurutani, Yoichi Nakamura, Katsumi Nakatomi, Hiroshi Soda, Mikio Oka, Mitsuhiro Suenaga, Ken Shiozawa, Yasuaki Y amada, Shigeru Kohno, Shimeru Kamihira, Seiji Doi
Publikováno v:
International journal of cancer. 104(2)
FR901228 is a novel histone deacetylase (HDAC) inhibitor, and its antiproliferative effects on non-small cell lung cancer cells have been shown in vitro. However, there have been no reports concerning the effects on small-cell lung cancer (SCLC). We